These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15699244)

  • 1. The peroxisome proliferator-activated receptor alpha Leu162Val polymorphism influences the metabolic response to a dietary intervention altering fatty acid proportions in healthy men.
    Paradis AM; Fontaine-Bisson B; Bossé Y; Robitaille J; Lemieux S; Jacques H; Lamarche B; Tchernof A; Couture P; Vohl MC
    Am J Clin Nutr; 2005 Feb; 81(2):523-30. PubMed ID: 15699244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARγ2 gene Pro12Ala and PPARα gene Leu162Val single nucleotide polymorphisms interact with dietary intake of fat in determination of plasma lipid concentrations.
    Alsaleh A; Frost GS; Griffin BA; Lovegrove JA; Jebb SA; Sanders TA; O'Dell SD;
    J Nutrigenet Nutrigenomics; 2011; 4(6):354-66. PubMed ID: 22378291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the PPAR-Alpha L162V polymorphism on the cardiovascular disease risk factor in response to n-3 polyunsaturated fatty acids.
    Caron-Dorval D; Paquet P; Paradis AM; Rudkowska I; Lemieux S; Couture P; Vohl MC
    J Nutrigenet Nutrigenomics; 2008; 1(4):205-12. PubMed ID: 19776627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of interaction between PPARG, PPARA and ADIPOQ gene variants and dietary fatty acids on plasma lipid profile and adiponectin concentration in a large intervention study.
    AlSaleh A; Sanders TA; O'Dell SD
    Proc Nutr Soc; 2012 Feb; 71(1):141-53. PubMed ID: 22040870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of apolipoprotein B xbaI polymorphism on plasma lipid response to dietary fat.
    López-Miranda J; Marín C; Castro P; Gómez P; González-Amieva A; Paz E; Bravo D; Ordovas JM; Jimenez-Pereperez J; Pérez-Jiménez F
    Eur J Clin Invest; 2000 Aug; 30(8):678-84. PubMed ID: 10964159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARalpha L162V polymorphism alters the potential of n-3 fatty acids to increase lipoprotein lipase activity.
    Rudkowska I; Caron-Dorval D; Verreault M; Couture P; Deshaies Y; Barbier O; Vohl MC
    Mol Nutr Food Res; 2010 Apr; 54(4):543-50. PubMed ID: 19937854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome.
    Robitaille J; Brouillette C; Houde A; Lemieux S; Pérusse L; Tchernof A; Gaudet D; Vohl MC
    J Hum Genet; 2004; 49(9):482-489. PubMed ID: 15309680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor [alpha] genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study.
    Volcik KA; Nettleton JA; Ballantyne CM; Boerwinkle E
    Am J Clin Nutr; 2008 Jun; 87(6):1926-31. PubMed ID: 18541586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human apolipoprotein A-I gene promoter mutation influences plasma low density lipoprotein cholesterol response to dietary fat saturation.
    Mata P; Lopez-Miranda J; Pocovi M; Alonso R; Lahoz C; Marin C; Garces C; Cenarro A; Perez-Jimenez F; de Oya M; Ordovas JM
    Atherosclerosis; 1998 Apr; 137(2):367-76. PubMed ID: 9622280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid saturation of the diet and plasma lipid concentrations, lipoprotein particle concentrations, and cholesterol efflux capacity.
    Montoya MT; Porres A; Serrano S; Fruchart JC; Mata P; Gerique JA; Castro GR
    Am J Clin Nutr; 2002 Mar; 75(3):484-91. PubMed ID: 11864853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary polyunsaturated fatty acids may increase plasma LDL-cholesterol and plasma cholesterol concentrations in carriers of an ABCG1 gene single nucleotide polymorphism: study in two Spanish populations.
    Abellán R; Mansego ML; Martínez-Hervás S; Morcillo S; Pineda-Alonso M; Carmena R; Real JT; Redon J; Rojo-Martínez G; Martín-Escudero JC; Chaves FJ
    Atherosclerosis; 2011 Dec; 219(2):900-6. PubMed ID: 21978921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The V227A polymorphism at the PPARA locus is associated with serum lipid concentrations and modulates the association between dietary polyunsaturated fatty acid intake and serum high density lipoprotein concentrations in Chinese women.
    Chan E; Tan CS; Deurenberg-Yap M; Chia KS; Chew SK; Tai ES
    Atherosclerosis; 2006 Aug; 187(2):309-15. PubMed ID: 16288935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes.
    Dullaart RP; Hoogenberg K; Riemens SC; Groener JE; van Tol A; Sluiter WJ; Stulp BK
    Diabetes; 1997 Dec; 46(12):2082-7. PubMed ID: 9392500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of diets enriched in n-6 or n-3 fatty acids on cholesterol metabolism in older rats chronically fed a cholesterol-enriched diet.
    Fukushima M; Ohhashi T; Ohno S; Saitoh H; Sonoyama K; Shimada K; Sekikawa M; Nakano M
    Lipids; 2001 Mar; 36(3):261-6. PubMed ID: 11337981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the Framingham Heart Study.
    Tai ES; Corella D; Demissie S; Cupples LA; Coltell O; Schaefer EJ; Tucker KL; Ordovas JM;
    J Nutr; 2005 Mar; 135(3):397-403. PubMed ID: 15735069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor alpha polymorphisms and postprandial lipemia in healthy men.
    Tanaka T; Ordovas JM; Delgado-Lista J; Perez-Jimenez F; Marin C; Perez-Martinez P; Gomez P; Lopez-Miranda J
    J Lipid Res; 2007 Jun; 48(6):1402-8. PubMed ID: 17363837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lycopene and apo-10'-lycopenoic acid have differential mechanisms of protection against hepatic steatosis in β-carotene-9',10'-oxygenase knockout male mice.
    Ip BC; Liu C; Lichtenstein AH; von Lintig J; Wang XD
    J Nutr; 2015 Feb; 145(2):268-76. PubMed ID: 25644347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOE4 Genotype Exerts Greater Benefit in Lowering Plasma Cholesterol and Apolipoprotein B than Wild Type (E3/E3), after Replacement of Dietary Saturated Fats with Low Glycaemic Index Carbohydrates.
    Griffin BA; Walker CG; Jebb SA; Moore C; Frost GS; Goff L; Sanders TAB; Lewis F; Griffin M; Gitau R; Lovegrove JA
    Nutrients; 2018 Oct; 10(10):. PubMed ID: 30336580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between smoking and the Sstl polymorphism of the apo C-III gene determines plasma lipid response to diet.
    Pérez-Martínez P; Gómez P; Paz E; Marín C; Gavilán Moral E; López-Miranda J; Ordovas JM; Fernandez de la Puebla RA; Pérez-Jiménez F
    Nutr Metab Cardiovasc Dis; 2001 Aug; 11(4):237-43. PubMed ID: 11837227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol-free diet with a high ratio of polyunsaturated to saturated fatty acids in heterozygous familial hypercholesterolemia: significant lowering effect on plasma cholesterol.
    Mokuno H; Yamada N; Sugimoto T; Kobayashi T; Ishibashi S; Shimano H; Takizawa M; Kawakami M; Takaku F; Murase T
    Horm Metab Res; 1990 Apr; 22(4):246-51. PubMed ID: 2351374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.